HK1127289A1 - Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol - Google Patents

Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol

Info

Publication number
HK1127289A1
HK1127289A1 HK09105733.2A HK09105733A HK1127289A1 HK 1127289 A1 HK1127289 A1 HK 1127289A1 HK 09105733 A HK09105733 A HK 09105733A HK 1127289 A1 HK1127289 A1 HK 1127289A1
Authority
HK
Hong Kong
Prior art keywords
paracetamol
dimethylamino
phenol
propyl
ethyl
Prior art date
Application number
HK09105733.2A
Other languages
English (en)
Inventor
Petra Bloms-Funke
Klaus Schiene
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37025148&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1127289(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of HK1127289A1 publication Critical patent/HK1127289A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK09105733.2A 2006-04-28 2009-06-25 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol HK1127289A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06008851 2006-04-28
PCT/EP2007/003632 WO2007128413A1 (en) 2006-04-28 2007-04-25 Pharmaceutical combination comprising 3- ( 3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol

Publications (1)

Publication Number Publication Date
HK1127289A1 true HK1127289A1 (en) 2009-09-25

Family

ID=37025148

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105733.2A HK1127289A1 (en) 2006-04-28 2009-06-25 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl- propyl) -phenol and paracetamol

Country Status (25)

Country Link
EP (1) EP2012764B1 (zh)
JP (2) JP5496653B2 (zh)
KR (1) KR101396166B1 (zh)
CN (1) CN101431990B (zh)
AT (1) ATE494889T1 (zh)
AU (1) AU2007247481B2 (zh)
BR (1) BRPI0710682B8 (zh)
CA (1) CA2650423C (zh)
CY (1) CY1111369T1 (zh)
DE (1) DE602007011913D1 (zh)
DK (1) DK2012764T3 (zh)
EC (2) ECSP088793A (zh)
ES (1) ES2356093T3 (zh)
HK (1) HK1127289A1 (zh)
HR (1) HRP20110076T1 (zh)
IL (1) IL194883A (zh)
MX (1) MX2008013779A (zh)
NO (2) NO341602B1 (zh)
NZ (1) NZ571442A (zh)
PL (1) PL2012764T3 (zh)
PT (1) PT2012764E (zh)
RU (1) RU2442576C2 (zh)
SI (1) SI2012764T1 (zh)
WO (1) WO2007128413A1 (zh)
ZA (1) ZA200810124B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007012165A1 (de) 2007-03-12 2008-09-18 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP2219633A2 (en) * 2007-11-23 2010-08-25 Nectid, Inc. Tapentadol compositions
KR101831616B1 (ko) 2010-06-15 2018-04-04 그뤼넨탈 게엠베하 통증 치료용 약제학적 병용물
MX351584B (es) 2011-03-04 2017-10-20 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral.
US20120225951A1 (en) * 2011-03-04 2012-09-06 Gruenenthal Gmbh Parenteral Administration of Tapentadol
EP2680834B1 (en) 2011-03-04 2017-10-18 Grünenthal GmbH Semisolid aqueous pharmaceutical composition containing tapentadol
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
EP2808319A1 (en) 2013-05-31 2014-12-03 Arevipharma GmbH 3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
LT3273953T (lt) 2015-03-27 2019-02-25 Grünenthal GmbH Stabili kompozicija, skirta tapentadolio skyrimui parenteriniu būdu
EP3515412A1 (en) 2016-09-23 2019-07-31 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
EP3585370A1 (en) 2017-02-23 2020-01-01 Grünenthal GmbH Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
EP1685829B1 (de) * 2002-11-22 2008-04-09 Grünenthal GmbH Verwendung von (1RS,3RS,6RS)-6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexan-1,3-diol zur Behandlung von Entzündungsschmerz

Also Published As

Publication number Publication date
BRPI0710682A2 (pt) 2011-08-23
PL2012764T3 (pl) 2011-04-29
ES2356093T3 (es) 2011-04-04
HRP20110076T1 (hr) 2011-02-28
KR101396166B1 (ko) 2014-05-27
RU2442576C2 (ru) 2012-02-20
EP2012764A1 (en) 2009-01-14
JP2009535313A (ja) 2009-10-01
KR20090006219A (ko) 2009-01-14
PT2012764E (pt) 2011-02-02
JP5496653B2 (ja) 2014-05-21
AU2007247481B2 (en) 2013-02-14
MX2008013779A (es) 2008-11-14
CN101431990A (zh) 2009-05-13
AU2007247481A1 (en) 2007-11-15
CY1111369T1 (el) 2015-08-05
ZA200810124B (en) 2009-08-26
NO341602B1 (no) 2017-12-11
CN101431990B (zh) 2011-08-03
DK2012764T3 (da) 2011-02-28
SI2012764T1 (sl) 2011-03-31
CA2650423A1 (en) 2007-11-15
NO20171831A1 (no) 2008-10-28
EP2012764B1 (en) 2011-01-12
BRPI0710682B1 (pt) 2020-09-24
ECSP17000643A (es) 2018-06-30
IL194883A (en) 2012-10-31
NO343505B1 (no) 2019-03-25
IL194883A0 (en) 2009-08-03
CA2650423C (en) 2014-08-12
JP2013213045A (ja) 2013-10-17
ATE494889T1 (de) 2011-01-15
NZ571442A (en) 2011-09-30
RU2008146816A (ru) 2010-06-10
BRPI0710682B8 (pt) 2021-05-25
WO2007128413A1 (en) 2007-11-15
DE602007011913D1 (de) 2011-02-24
NO20084542L (no) 2008-10-28
ECSP088793A (es) 2008-11-27

Similar Documents

Publication Publication Date Title
ECSP17000643A (es) Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol.
MX2008013828A (es) Combinacion farmaceutica que comprende 3-(3-dimetilanimo-1-etil-2- metil-propil)-fenol y un nsaid.
WO2010025931A3 (en) Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2 -methyl-propyl) - phenol and an antiepileptic
AU2016219643A1 (en) Pharmaceutical combination for the treatment of pain
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
WO2013158680A3 (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
WO2008148074A3 (en) Inhibitors of mtor and methods of treatment using same
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
BRPI0922789A2 (pt) peptídeo de ligação de albumina intermediador para reconhecimento de doença
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
WO2007138466A3 (en) Pharmaceutical compositions comprising meloxicam and tramadol combination
WO2008124505A3 (en) Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders
UA103614C2 (uk) Лікарський засіб, що містить комбінацію інгібітора кінази та анти-гліпікан 3-антитіла, для лікування раку печінки
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
WO2006055352A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
HK1176318A1 (en) Injection device
WO2007056236A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
MX2009011900A (es) Curacion de herida diabetica.
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
WO2008012796A3 (en) Pharmaceutical compositions comprising ccl2 and use of same for the treatment of inflammation
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
TW200744676A (en) Pharmaceutical compositions for the eradication of helicobacter pylori
WO2007084383A3 (en) Method and composition for the treatment of parkinson's disease